Redox Biology · 2017 · 154 citations · 33 references
MedicineCardiologyPharmacologyBiochemical PharmacologyCardiovascular PharmacotherapyClinical PharmacologyCardiovascular Molecular PhysiologyEndothelial DysfunctionIschemic Heart DiseaseCardioprotective TherapyIschemia-reperfusion Oxidative InjuryMyocardial Ischemia-reperfusion InjuryNf-κb SignalingNitric OxideNitric Oxide Synthase RegulationOxidative Stress In Ischemia-reperfusion InjuryOxidative Stress Injury
Caffeic acid phenethyl ester (CAPE) could ameliorate myocardial ischemia/reperfusion injury (MIRI) by various mechanisms, but there hadn’t been any reports on that CAPE could regulate silent information regulator 1 (SIRT1) and endothelial nitric oxide synthase (eNOS) to exert cardioprotective effect. The present study aimed to investigate the cardioprotective potential of caffeic acid o-nitro phenethyl ester (CAPE-oNO2) on MIRI and the possible mechanism based on the positive control of CAPE. The SD rats were subjected to left coronary artery ischemia /reperfusion (IR) and the H9c2 cell cultured in hypoxia/reoxygenation (HR) to induce the MIRI model. Prior to the procedure, vehicle, CAPE or CAPE-oNO2 were treated in the absence or presence of a SIRT1 inhibitor nicotinamide (NAM) and an eNOS inhibitor Nω-nitro-L-arginine methyl ester (L-NAME). In vivo, CAPE and CAPE-oNO2 conferred a cardioprotective effect as shown by reduced myocardial infarct size, cardiac marker enzymes and structural abnormalities. From immunohistochemical and sirius red staining, above two compounds ameliorated the TNF-α release and collagen deposition of IR rat hearts. They could agitate SIRT1 and eNOS expression, and consequently enhance NO release and suppress NF-κB signaling, to reduce the malondialdehyde content and cell necrosis. In vitro, they could inhibit HR-induced H9c2 cell apoptosis and ROS generation by activating SIRT1/eNOS pathway and inhabiting NF-κB expression. Emphatically, CAPE-oNO2 presented the stronger cardioprotection than CAPE both in vivo and in vitro. However, NAM and L-NAME eliminated the CAPE-oNO2-mediated cardioprotection by restraining SIRT1 and eNOS expression, respectively. It suggested that CAPE-oNO2 ameliorated MIRI by suppressing the oxidative stress, inflammatory response, fibrosis and necrocytosis via the SIRT1/eNOS/NF-κB pathway.
33
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Fan Yeung, Jamie E. Hoberg, C S Ramsey et al. · The EMBO Journal · 2004 · 2.7K citations · Full text
Sirt1 Regulates Aging and Resistance to Oxidative Stress in the Heart
Ralph R. Alcendor, Shumin Gao, Peiyong Zhai et al. · Circulation Research · 2007 · 1.1K citations
Control of coronary vascular tone by nitric oxide.
Malte Kelm, Jürgen Schrader · Circulation Research · 1990 · 702 citations
Medicine, Cardiology, Pharmacology +13